MarketGrader US Indexes
US Core
US Large Cap Select Index US Large Cap 100 Index US Large Cap 200 Index US Mid Cap 100 Index US Small Cap (ex-Mid) 100 Index US Small Cap Core 100 Index Barron's 400 Index U.S. All-Cap 100 Index
US Style
US Large Cap Growth Index US Large Cap Value Index
US Income
US Income 100 Index US All Cap Income 100 Index
US Sectors
US Consumer Discretionary Index US Consumer Staples Index US Energy Index US Financials Index US Health Care Index US Industrials Index US Materials Index US Technology Index
US Thematic
U.S. Growth Compounders Index
MarketGrader Developed Markets Indexes
Developed Markets Core
Europe 100 Index Europe Small Cap 200 Index UK 50 Index UK Small Cap 100 Index Japan 100 Index Japan Small Cap 200 Index Australia Large Cap 30 Index Australia Small Cap 80 Index Israel Index Israel All-Cap 40 Index Canada Large Cap 40 Index Canada Small Cap 60 Index
Developed Markets Sectors
Developed Markets (ex-US) Health Care Index Developed Markets (ex-Australia) Health Care Index
Developed Markets Income
Developed Markets (ex-US) Income 200 Index Developed Markets (ex-US) Income 100 Index Developed Markets (ex-US) High Dividend Yield 100 Index Australia High Dividend Yield 30 Index Australia Income 30 Index
MarketGrader Emerging Markets Indexes
Emerging Markets Core
Emerging Markets 200 Index Emerging Markets 200 (Country Capped) Index Emerging Markets 100 Index Emerging Markets 100 (Country Capped) Index Emerging Markets (ex-China) 100 Index India Large Cap 50 Index India All-Cap Growth Leaders Index China All-Cap Growth Leaders Index Brazil 30 Index Brazil All-Cap Growth Leaders Index
Emerging Markets Sectors
China Consumer Discretionary Index China Consumer Staples Index China Health Care Index China Technology Index
Emerging Markets Thematic
China New Economy Index New China ESG Index China New Elite Index MILA (LatAm) 40 Index
MarketGrader Model Portfolios
US Core Portfolio US Growth Compounding Portfolio
MarketGrader - Global Indexes Report Card: Q1 2024

MarketGrader - Global Indexes Report Card: Q1 2024
MarketGrader Equity Ratings Overview

MarketGrader Ratings Overview

MarketGrader US Health Care Index


Five Largest Companies
Symbol Name Grade Market Cap Country
UNH UnitedHealth Group Incorporated 38.3 ¤445,420 US
ABT Abbott Laboratories 41.5 ¤184,432 US
AMGN Amgen Inc. 52.0 ¤148,648 US
SYK Stryker Corporation 60.9 ¤124,772 US
MDT Medtronic Plc 54.0 ¤107,407 IE

Five Smallest Companies
Symbol Name Grade Market Cap Country
AMLX Amylyx Pharmaceuticals, Inc. 71.8 ¤131 US
ADUS Addus HomeCare Corporation 61.1 ¤1,611 US
CPRX Catalyst Pharmaceuticals, Inc. 75.2 ¤1,792 US
LNTH Lantheus Holdings Inc 89.0 ¤4,620 US
OGN Organon & Co. 52.4 ¤4,814 US

Companies with Most Selections Among Current Components
Symbol Name Grade Times* Country
AMGN Amgen Inc. 52.0 29 US
UNH UnitedHealth Group Incorporated 38.3 29 US
CHE Chemed Corporation 58.7 25 US
BMY Bristol-Myers Squibb Company 34.4 20 US
WST West Pharmaceutical Services, Inc. 53.8 19 US
ZTS Zoetis, Inc. Class A 58.2 19 US
GILD Gilead Sciences, Inc. 55.0 17 US
RMD ResMed Inc. 68.0 16 US
TFX Teleflex Incorporated 45.4 15 US
A Agilent Technologies, Inc. 59.9 14 US
*Number of times selected at Index semi-annual reconstitutions since inception date.
Index Bio
Average Market Cap ¤55,286
Median Market Cap ¤13,847
Avg. 3 Mo. Dollar Vol. ¤294,677,050
Avg. 3 Mo. Trading Vol. 2,812,290
Last Rebalance Date 03/18/2024
Companies Replaced 18
Biggest Sector Increase Health Care
Biggest Sector Decrease Health Care

Fundamental Attributes
Trailing P/E Ratio (12 Mo.) 25.7
Forward P/E Ratio (12 Mo.) 15.4
Price/Book Ratio 4.8
Avg. Revenue Chg. - 3 Yr 28.0%
Avg. Op. Income Chg. - 3 Yr. 24.0%
Avg. EPS Growth - 3 Yr. 5.1%
Avg. EPS Growth - 1 Yr. 10.3%
Avg. Operating Margin 18.7%
Avg. LT Debt to Total Capital 35.4%
Avg. Return on Equity 20.8%
Dividend Yield 0.7%
Index Average Grade
US Health Care Index 57.46
Country Breakdown
United States Of America 90.0%
Ireland 6.67%
United Kingdom 3.33%
For more information on this index please contact us

Get Access to the World's Smartest Global Research Platform

Don't wait another day to make better informed, higher-returning investments.

TRY IT FOR FREE